Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 02/11/2025 12:35:43 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 1504
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
71010
I just happened to stop by. So sorry to read that
(3)
BooDog
01/11/2022 6:23:31 AM
70996
So sorry to hear about Alan C. My sincere
(5)
Fit007
01/03/2022 12:18:40 PM
70995
I appreciated Alan Cs daily report on trading.
(3)
Jimvette
01/03/2022 11:02:19 AM
70994
AlanC regrettably passed away.
(2)
someconcerns
01/03/2022 9:59:49 AM
70993
Does anyone know whereabout AlanC?
Zadie
01/03/2022 7:30:45 AM
70992
Early, but new variant possibly greater than
(1)
djs7
01/02/2022 11:18:15 PM
70991
Let's pray Brilacidin can find its specific path
(1)
djs7
01/02/2022 10:19:43 PM
70987
Found this post on another site. Am currently
(7)
petemantx
12/30/2021 4:49:55 PM
70982
Hope everyone had a Merry Christmas and is
(7)
scgmck1
12/29/2021 10:25:24 PM
70980
Initially I was very disturbed with the PR
(8)
petemantx
12/27/2021 8:38:39 PM
70979
As frustrations mount over the need for, what
(2)
Commando911
12/27/2021 12:52:02 AM
70978
So if you have migraines or certain heart
(3)
Drano
12/27/2021 12:07:13 AM
70977
Ritonavir, part of part of Pfizer's covid pill
(5)
farrell
12/26/2021 11:43:01 PM
70976
Great post farrell. We have all read about safety
(6)
Mo
12/26/2021 11:49:20 AM
70975
At this point none of the other antiviral drugs
(11)
farrell
12/26/2021 10:59:11 AM
70972
Thanks and same to you and the board as well.
(3)
Kelt
12/25/2021 3:14:01 PM
70968
Second the motion. Merry Christmas and let's hope
(5)
Drano
12/25/2021 11:02:42 AM
70967
Merry Christmas to you and all who
(5)
someconcerns
12/25/2021 6:31:36 AM
70966
Merry Christmas, folks!
(5)
Commando911
12/24/2021 10:56:00 PM
70965
Maybe Leo will apply for a NIIMBL grant from the
Commando911
12/23/2021 10:04:23 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
Newer
Older
Recent Articles
Eric Hansen's Leadership Shines as CWCI Chair for 2025
Rexel's Stock and Voting Rights Update: Key Insights
Important Insights from ABC Arbitrage's Upcoming General Meeting
Suzanne Snapper Joins The Pennant Group's Board of Directors
Mitsubishi Logisnext Americas to Launch a New Experience Center
Celebrating Innovative Winners of EarthX Climate Tech Awards
Empowering Restaurants: American Express Grant Program Returns
Explore the All-New Jeep Rooftop Tent Concept for Adventurers
Vectara Partners with Anywhere Real Estate to Enhance Workflow
2025 London Real Estate Market Forecast
Shell's Recent Share Buyback Program Details and Insights
Kering's Latest Shares & Voting Rights Update - May 2025
Significant Growth in the Live Cell Imaging Market Ahead
Driving AI Innovation: VIDIZMO at GITEX EUROPE 2025 Event
Houston County Jail Enhances Operations with OverWatch™ Technology
Automotive Heat Shield Market Growth Expected by 2030: Key Insights
Hisense's Spectacular Showcase at the Cannes Film Festival
Investigation of Charter Communications and Inozyme Pharma Shares
Unlocking Trillions: Jim Rickards on U.S. Resource Potential
Unlocking Passive Income with PAIRMiner's Bitcoin Mining
Totaligent, Inc. Enhances Teams for Future Marketing Innovations
AKWEL Faces Expected Charge Impacting Financial Year Profitability
SmartCentres' May 2025 Distribution Announcement Details
Key Insights into Dassault Aviation's Share Buyback Plan
Avance Gas Holding Ltd's Shareholder Decisions and Future Plans
Innovative Insights: Waters Corporation at Global Healthcare Event
Exploring the Future of the Global Sportswear Market
Dr. Britta Will Named to Lead Stem Cell Research Institute
Flowcore's Rebranding: A New Era in Water Solutions
Hisense Showcases Innovation and Design at Cannes Film Festival
Bitfarms Faces Class Action Lawsuit Amid Securities Violations
Exciting Highlights from the Wonderful Regeneron ISEF Awards
DXC Technology Shine in Forbes 2025 Consulting Ranking
Zscaler Expands with Major New Headquarters in Silicon Valley
Honoring Military Service: New Stamp Release for Armed Forces
Seminole Hard Rock Tampa Crowned as Top Luckiest Casino
Launch of Vonn Vanier's Debut Album 'Dawn' on Montclair Records
Compass Diversified Investors Under Legal Scrutiny Amid Claims
Zynex Investors Urged on Class Action Lawsuit Options
Innovative siRNA Drug SNS812 Selected for 2025 ATS Presentation
Unveiling CreateLED's Groundbreaking MicroLED Innovations
Understanding the Recent West Pharmaceutical Services Lawsuit
Investigation on Zenas BioPharma Class Action Alert for Investors
JA Mining's Innovative Cloud Platform Revolutionizes Asset Mining
Kaanch Network: The Next Big Opportunity in Crypto Investments
Leadership Changes at Harvia: A New Chapter Begins
Exciting Announcement: Toll Brothers' Upcoming Luxury Community
S4 Capital's Monks: A Leader in AI-Powered Marketing Solutions
Understanding Your Rights After Open Lending's Legal Challenges
Columbus McKinnon Announces Earnings Call for Fiscal Insights